Local view for "http://purl.org/linkedpolitics/eu/plenary/2007-04-23-Speech-1-111"

PredicateValue (sorted: none)
lpv:spokenAs
lpv:spokenAs
lpv:spokenAs
lpv:spokenAs
lpv:spokenAs
lpv:spokenAs
lpv:spokenAs
lpv:translated text
"Mr President, I would like to thank those Members who participated in the detailed processing of this regulation. It is extremely important that issues as sensitive and complex as this are dealt with under the codecision procedure. It reassures our citizens, whose national parliaments cannot vary a regulation, to see their MEPs engaged in preparing balanced and effective legislation which seeks to enhance their lives. The therapies which this regulation seeks to deal with have great potential for treating cancer, Alzheimer’s and Parkinson’s disease. Regrettably, and not unexpectedly, some reactionary elements are falsely claiming that this proposal overrides Member States’ rights on ethical issues. They want to exclude products derived from embryonic stem cells from the scope of this regulation. The effect of doing so would be to leave such products unregulated in many parts of Europe as regards their safety, quality and efficacy. Contrary to these wild claims, the regulation does not circumscribe a Member State’s right to refuse to countenance embryo, stem-cell-based therapies. Indeed I would deplore such a ban by any Member State. This regulation is about saving life and about enhancing the quality of life, not its destruction – as is being claimed by some in this House tonight. We owe it to tens of thousands of patients and their families to do everything we can to encourage and make available the most advanced treatments for some of the most intractable illnesses facing our societies today. We also need to guarantee insofar as we can that they are safe and of the highest quality and that they actually work. This is what this regulation seeks to do. I fully support the PSE Group’s position and call on all Members – and indeed I would particularly call on all my Irish colleagues – to support this regulation."@ro18
lpv:unclassifiedMetadata
"Proinsias De Rossa (PSE ). –"18,5,20,15,1,19,14,16,11,13,4
lpv:unclassifiedMetadata
"Proinsias De Rossa (PSE ). –"18,5,20,15,1,19,14,16,11,13,4
lpv:translated text
"Mr President, I would like to thank those Members who participated in the detailed processing of this regulation. It is extremely important that issues as sensitive and complex as this are dealt with under the codecision procedure. It reassures our citizens, whose national parliaments cannot vary a regulation, to see their MEPs engaged in preparing balanced and effective legislation which seeks to enhance their lives. The therapies which this regulation seeks to deal with have great potential for treating cancer, Alzheimer’s and Parkinson’s disease. Regrettably, and not unexpectedly, some reactionary elements are falsely claiming that this proposal overrides Member States’ rights on ethical issues. They want to exclude products derived from embryonic stem cells from the scope of this regulation. The effect of doing so would be to leave such products unregulated in many parts of Europe as regards their safety, quality and efficacy. Contrary to these wild claims, the regulation does not circumscribe a Member State’s right to refuse to countenance embryo, stem-cell-based therapies. Indeed I would deplore such a ban by any Member State. This regulation is about saving life and about enhancing the quality of life, not its destruction – as is being claimed by some in this House tonight. We owe it to tens of thousands of patients and their families to do everything we can to encourage and make available the most advanced treatments for some of the most intractable illnesses facing our societies today. We also need to guarantee insofar as we can that they are safe and of the highest quality and that they actually work. This is what this regulation seeks to do. I fully support the PSE Group’s position and call on all Members – and indeed I would particularly call on all my Irish colleagues – to support this regulation."@et5
lpv:unclassifiedMetadata
"Proinsias De Rossa (PSE ). –"18,5,20,15,1,19,14,16,11,13,4
lpv:translated text
"Mr President, I would like to thank those Members who participated in the detailed processing of this regulation. It is extremely important that issues as sensitive and complex as this are dealt with under the codecision procedure. It reassures our citizens, whose national parliaments cannot vary a regulation, to see their MEPs engaged in preparing balanced and effective legislation which seeks to enhance their lives. The therapies which this regulation seeks to deal with have great potential for treating cancer, Alzheimer’s and Parkinson’s disease. Regrettably, and not unexpectedly, some reactionary elements are falsely claiming that this proposal overrides Member States’ rights on ethical issues. They want to exclude products derived from embryonic stem cells from the scope of this regulation. The effect of doing so would be to leave such products unregulated in many parts of Europe as regards their safety, quality and efficacy. Contrary to these wild claims, the regulation does not circumscribe a Member State’s right to refuse to countenance embryo, stem-cell-based therapies. Indeed I would deplore such a ban by any Member State. This regulation is about saving life and about enhancing the quality of life, not its destruction – as is being claimed by some in this House tonight. We owe it to tens of thousands of patients and their families to do everything we can to encourage and make available the most advanced treatments for some of the most intractable illnesses facing our societies today. We also need to guarantee insofar as we can that they are safe and of the highest quality and that they actually work. This is what this regulation seeks to do. I fully support the PSE Group’s position and call on all Members – and indeed I would particularly call on all my Irish colleagues – to support this regulation."@sl20
lpv:unclassifiedMetadata
"Proinsias De Rossa (PSE ). –"18,5,20,15,1,19,14,16,11,13,4
lpv:translated text
"Mr President, I would like to thank those Members who participated in the detailed processing of this regulation. It is extremely important that issues as sensitive and complex as this are dealt with under the codecision procedure. It reassures our citizens, whose national parliaments cannot vary a regulation, to see their MEPs engaged in preparing balanced and effective legislation which seeks to enhance their lives. The therapies which this regulation seeks to deal with have great potential for treating cancer, Alzheimer’s and Parkinson’s disease. Regrettably, and not unexpectedly, some reactionary elements are falsely claiming that this proposal overrides Member States’ rights on ethical issues. They want to exclude products derived from embryonic stem cells from the scope of this regulation. The effect of doing so would be to leave such products unregulated in many parts of Europe as regards their safety, quality and efficacy. Contrary to these wild claims, the regulation does not circumscribe a Member State’s right to refuse to countenance embryo, stem-cell-based therapies. Indeed I would deplore such a ban by any Member State. This regulation is about saving life and about enhancing the quality of life, not its destruction – as is being claimed by some in this House tonight. We owe it to tens of thousands of patients and their families to do everything we can to encourage and make available the most advanced treatments for some of the most intractable illnesses facing our societies today. We also need to guarantee insofar as we can that they are safe and of the highest quality and that they actually work. This is what this regulation seeks to do. I fully support the PSE Group’s position and call on all Members – and indeed I would particularly call on all my Irish colleagues – to support this regulation."@mt15
lpv:unclassifiedMetadata
"Proinsias De Rossa (PSE ). –"18,5,20,15,1,19,14,16,11,13,4
lpv:translated text
"Mr President, I would like to thank those Members who participated in the detailed processing of this regulation. It is extremely important that issues as sensitive and complex as this are dealt with under the codecision procedure. It reassures our citizens, whose national parliaments cannot vary a regulation, to see their MEPs engaged in preparing balanced and effective legislation which seeks to enhance their lives. The therapies which this regulation seeks to deal with have great potential for treating cancer, Alzheimer’s and Parkinson’s disease. Regrettably, and not unexpectedly, some reactionary elements are falsely claiming that this proposal overrides Member States’ rights on ethical issues. They want to exclude products derived from embryonic stem cells from the scope of this regulation. The effect of doing so would be to leave such products unregulated in many parts of Europe as regards their safety, quality and efficacy. Contrary to these wild claims, the regulation does not circumscribe a Member State’s right to refuse to countenance embryo, stem-cell-based therapies. Indeed I would deplore such a ban by any Member State. This regulation is about saving life and about enhancing the quality of life, not its destruction – as is being claimed by some in this House tonight. We owe it to tens of thousands of patients and their families to do everything we can to encourage and make available the most advanced treatments for some of the most intractable illnesses facing our societies today. We also need to guarantee insofar as we can that they are safe and of the highest quality and that they actually work. This is what this regulation seeks to do. I fully support the PSE Group’s position and call on all Members – and indeed I would particularly call on all my Irish colleagues – to support this regulation."@cs1
lpv:unclassifiedMetadata
"Proinsias De Rossa (PSE ). –"18,5,20,15,1,19,14,16,11,13,4
lpv:translated text
"Mr President, I would like to thank those Members who participated in the detailed processing of this regulation. It is extremely important that issues as sensitive and complex as this are dealt with under the codecision procedure. It reassures our citizens, whose national parliaments cannot vary a regulation, to see their MEPs engaged in preparing balanced and effective legislation which seeks to enhance their lives. The therapies which this regulation seeks to deal with have great potential for treating cancer, Alzheimer’s and Parkinson’s disease. Regrettably, and not unexpectedly, some reactionary elements are falsely claiming that this proposal overrides Member States’ rights on ethical issues. They want to exclude products derived from embryonic stem cells from the scope of this regulation. The effect of doing so would be to leave such products unregulated in many parts of Europe as regards their safety, quality and efficacy. Contrary to these wild claims, the regulation does not circumscribe a Member State’s right to refuse to countenance embryo, stem-cell-based therapies. Indeed I would deplore such a ban by any Member State. This regulation is about saving life and about enhancing the quality of life, not its destruction – as is being claimed by some in this House tonight. We owe it to tens of thousands of patients and their families to do everything we can to encourage and make available the most advanced treatments for some of the most intractable illnesses facing our societies today. We also need to guarantee insofar as we can that they are safe and of the highest quality and that they actually work. This is what this regulation seeks to do. I fully support the PSE Group’s position and call on all Members – and indeed I would particularly call on all my Irish colleagues – to support this regulation."@sk19
lpv:unclassifiedMetadata
"Proinsias De Rossa (PSE ). –"18,5,20,15,1,19,14,16,11,13,4
lpv:translated text
"Mr President, I would like to thank those Members who participated in the detailed processing of this regulation. It is extremely important that issues as sensitive and complex as this are dealt with under the codecision procedure. It reassures our citizens, whose national parliaments cannot vary a regulation, to see their MEPs engaged in preparing balanced and effective legislation which seeks to enhance their lives. The therapies which this regulation seeks to deal with have great potential for treating cancer, Alzheimer’s and Parkinson’s disease. Regrettably, and not unexpectedly, some reactionary elements are falsely claiming that this proposal overrides Member States’ rights on ethical issues. They want to exclude products derived from embryonic stem cells from the scope of this regulation. The effect of doing so would be to leave such products unregulated in many parts of Europe as regards their safety, quality and efficacy. Contrary to these wild claims, the regulation does not circumscribe a Member State’s right to refuse to countenance embryo, stem-cell-based therapies. Indeed I would deplore such a ban by any Member State. This regulation is about saving life and about enhancing the quality of life, not its destruction – as is being claimed by some in this House tonight. We owe it to tens of thousands of patients and their families to do everything we can to encourage and make available the most advanced treatments for some of the most intractable illnesses facing our societies today. We also need to guarantee insofar as we can that they are safe and of the highest quality and that they actually work. This is what this regulation seeks to do. I fully support the PSE Group’s position and call on all Members – and indeed I would particularly call on all my Irish colleagues – to support this regulation."@lt14
lpv:unclassifiedMetadata
"Proinsias De Rossa (PSE ). –"18,5,20,15,1,19,14,16,11,13,4
lpv:translated text
"Mr President, I would like to thank those Members who participated in the detailed processing of this regulation. It is extremely important that issues as sensitive and complex as this are dealt with under the codecision procedure. It reassures our citizens, whose national parliaments cannot vary a regulation, to see their MEPs engaged in preparing balanced and effective legislation which seeks to enhance their lives. The therapies which this regulation seeks to deal with have great potential for treating cancer, Alzheimer’s and Parkinson’s disease. Regrettably, and not unexpectedly, some reactionary elements are falsely claiming that this proposal overrides Member States’ rights on ethical issues. They want to exclude products derived from embryonic stem cells from the scope of this regulation. The effect of doing so would be to leave such products unregulated in many parts of Europe as regards their safety, quality and efficacy. Contrary to these wild claims, the regulation does not circumscribe a Member State’s right to refuse to countenance embryo, stem-cell-based therapies. Indeed I would deplore such a ban by any Member State. This regulation is about saving life and about enhancing the quality of life, not its destruction – as is being claimed by some in this House tonight. We owe it to tens of thousands of patients and their families to do everything we can to encourage and make available the most advanced treatments for some of the most intractable illnesses facing our societies today. We also need to guarantee insofar as we can that they are safe and of the highest quality and that they actually work. This is what this regulation seeks to do. I fully support the PSE Group’s position and call on all Members – and indeed I would particularly call on all my Irish colleagues – to support this regulation."@pl16
lpv:unclassifiedMetadata
"Proinsias De Rossa (PSE ). –"18,5,20,15,1,19,14,16,11,13,4
lpv:translated text
"Mr President, I would like to thank those Members who participated in the detailed processing of this regulation. It is extremely important that issues as sensitive and complex as this are dealt with under the codecision procedure. It reassures our citizens, whose national parliaments cannot vary a regulation, to see their MEPs engaged in preparing balanced and effective legislation which seeks to enhance their lives. The therapies which this regulation seeks to deal with have great potential for treating cancer, Alzheimer’s and Parkinson’s disease. Regrettably, and not unexpectedly, some reactionary elements are falsely claiming that this proposal overrides Member States’ rights on ethical issues. They want to exclude products derived from embryonic stem cells from the scope of this regulation. The effect of doing so would be to leave such products unregulated in many parts of Europe as regards their safety, quality and efficacy. Contrary to these wild claims, the regulation does not circumscribe a Member State’s right to refuse to countenance embryo, stem-cell-based therapies. Indeed I would deplore such a ban by any Member State. This regulation is about saving life and about enhancing the quality of life, not its destruction – as is being claimed by some in this House tonight. We owe it to tens of thousands of patients and their families to do everything we can to encourage and make available the most advanced treatments for some of the most intractable illnesses facing our societies today. We also need to guarantee insofar as we can that they are safe and of the highest quality and that they actually work. This is what this regulation seeks to do. I fully support the PSE Group’s position and call on all Members – and indeed I would particularly call on all my Irish colleagues – to support this regulation."@hu11
lpv:translated text
"Hr. formand! Jeg vil gerne takke de medlemmer, der deltog i den detaljerede behandling af denne forordning. Det er ekstremt vigtigt, at sådanne følsomme og komplicerede spørgsmål er omfattet af den fælles beslutningsprocedure. Det beroliger borgerne i de enkelte lande, hvor de nationale parlamenter ikke har mulighed for at ændre en forordning, at deres repræsentanter i Europa-Parlamentet er involveret i udarbejdelsen af en afbalanceret og effektiv lovgivning, der har til formål at øge deres livskvalitet. De behandlingsformer, der er omfattet af denne forordning, åbner store muligheder for behandling af kræft, Alzheimers og Parkinsons syge. Desværre, og ikke uventet, hævder visse reaktionære kræfter fejlagtigt, at medlemsstaternes rettigheder på det etiske område tilsidesættes med dette forslag. De ønsker at undtage produkter fremstillet af embryonale stamceller fra forordningens anvendelsesområde. Dette vil betyde, at produkternes sikkerhed, kvalitet og virkning fortsat ikke vil blive omfattet af regulering i mange medlemsstater. I modsætning til, hvad der er blevet fremført i forbindelse med disse vilde beskyldninger, begrænser denne forordning ikke medlemsstaternes ret til at støtte behandlingsformer baseret på embryonale stamceller. Jeg ville rent faktisk tage afstand fra ethvert forbud af denne art i medlemsstaterne. Formålet med denne forordning er at redde liv og øge livskvaliteten og ikke at ødelægge den, som visse medlemmer har hævdet i aften. Vi skylder de titusindvis af patienter og familier at gøre vores yderste for at fremme og sikre de mest avancerede behandlingsformer for nogle af de mest komplicerede sygdomme, som samfundet står over for i dag. Vi er også nødt til i muligt omfang at garantere, at de er sikre og af højeste kvalitet, og at de rent faktisk virker. Det er formålet med denne forordning. Jeg støtter fuldt ud PSE-Gruppens holdning og opfordrer alle medlemmer - herunder navnlig alle mine irske kolleger - til at støtte denne forordning."@da2
lpv:translated text
"Arvoisa puhemies, haluan kiittää jäseniä, jotka ovat osallistuneet tämän asetuksen yksityiskohtaiseen käsittelyyn. On erittäin tärkeää, että asioita, jotka ovat yhtä arkaluonteisia ja monimutkaisia kuin tässä esillä oleva asia, käsitellään yhteispäätösmenettelyssä. Kansalaisiamme, joiden kotimaan parlamentit eivät voi panna täytäntöön asetusta epäyhtenäisesti, rauhoittaa huomata, että heidän Euroopan parlamentissa olevat edustajansa valmistelevat tasapainoista ja tehokasta lainsäädäntöä, jolla pyritään parantamaan heidän elämäänsä. Niihin terapioihin, joita tällä asetuksella pyritään sääntelemään, sisältyy paljon mahdollisuuksia syöpähoitojen sekä Alzheimerin tautiin ja Parkinsonin tautiin annettavien hoitojen aloilla. On valitettavaa, joskaan ei yllättävää, että eräät taantumukselliset tahot väittävät harhaanjohtavasti, että tämä ehdotus loukkaa jäsenvaltioiden oikeuksia eettisissä kysymyksissä. Nämä tahot haluavat jättää alkioiden kantasoluista johdetut lääkkeet asetuksen soveltamisalan ulkopuolelle. Seuraus olisi se, että tällaisten lääkkeiden turvallisuus, laatu ja teho jäisivät EU:ssa monin paikoin sääntelemättä. Toisin kuin näissä villeissä väitteissä esitetään, asetuksella ei rajoiteta jäsenvaltion oikeutta kieltäytyä hyväksymästä alkioihin ja kantasoluihin perustuvia terapioita. Olisin kuitenkin pahoillani tällaisesta kiellosta jossakin jäsenvaltiossa. Tässä asetuksessa kyse on elämän säästämisestä ja elämänlaadusta, ei elämän tuhoamisesta – kuten eräät tässä parlamentissa tänä iltana väittävät. Olemme kymmenille tuhansille potilaille ja heidän perheilleen velkaa sen, että teemme kaikkemme edistääksemme ja tuodaksemme saataville kaikkein edistyneimpiä hoitoja eräisiin kaikkein vaikeimmin hoidettaviin nykypäivän tauteihin. Lisäksi meidän on taattava parhaan kykymme mukaan näiden hoitojen turvallisuus ja mahdollisimman korkea laatu sekä niiden todellinen teho. Tämä on se, mihin tällä asetuksella pyritään. Tuen täysin PSE-ryhmän kantaa ja kehotan kaikkia jäseniä – ja erityisesti kaikkia irlantilaisia kollegojani – tukemaan tätä asetusta."@fi7
lpv:translated text
"Mijnheer de Voorzitter, ik dank de afgevaardigden die hebben deelgenomen aan de uitvoerige verwerking van deze verordening. Het is uiterst belangrijk dat gevoelige en complexe kwesties als deze op grond van de medebeslissingsprocedure worden behandeld. Het is geruststellend voor onze burgers, wier nationale parlement niet van een verordening kan afwijken, om te zien dat hun Europese afgevaardigden zich inspannen om tot uitgebalanceerde en doelmatige wetgeving te komen die bedoeld is om hun leven te verbeteren. De therapieën waarop deze verordening is gericht, bieden veel mogelijkheden bij de behandeling van kanker, de ziekte van Alzheimer en de ziekte van Parkinson. Helaas, en niet onverwacht, beweren reactionaire elementen ten onrechte dat dit voorstel voorbijgaat aan de rechten van de lidstaten inzake ethische kwesties. Ze willen producten die zijn afgeleid van embryonale stamcellen, uit het toepassingsgebied van deze verordening schrappen, met als gevolg dat er in grote delen van Europa voor dergelijke producten geen regelgeving inzake veiligheid, kwaliteit en werkzaamheid komt. In tegenstelling tot deze wilde beweringen beperkt de verordening niet het recht van een lidstaat om op embryo’s en stamcellen gebaseerde therapieën te verbieden. Ik zou een dergelijk verbod door een lidstaat overigens wel betreuren. Deze verordening is bedoeld om levens te redden en om de kwaliteit van het leven te verbeteren, niet om het te vernietigen – zoals sommigen in dit Parlement vanavond beweren. We zijn het tienduizenden patiënten en hun familieleden verschuldigd er alles aan te doen om de meest geavanceerde behandelingen voor een aantal van de hardnekkigste ziekten waarmee we tegenwoordig in onze samenleving worden geconfronteerd, te stimuleren en beschikbaar te stellen. We moeten ook zoveel mogelijk garanties bieden dat deze behandelingen veilig en van de hoogste kwaliteit zijn en dat ze echt werken. Daar is deze verordening voor bedoeld. Ik sta volledig achter het standpunt van de Sociaal-democratische Fractie in het Europees Parlement en doe een beroep op alle afgevaardigden – en met name al mijn Ierse collega’s – om deze verordening te steunen."@nl3
lpv:translated text
"Herr talman! Jag vill tacka de ledamöter som deltog i den ingående behandlingen av denna förordning. Det är oerhört viktigt att så känsliga och invecklade frågor som dessa behandlas enligt medbeslutandeförfarandet. Det är lugnande för våra medborgare, vars nationella parlament inte kan ändra en förordning, att se sina parlamentsledamöter vara med och ta fram en väl avvägd och effektiv lagstiftning med målsättningen att förbättra deras liv. De behandlingsformer som man försöker ta itu med i denna förordning har stor potential inom behandling av cancer, Alzheimers och Parkinsons sjukdom. Tyvärr, men inte oväntat, påstår vissa reaktionärer med orätt att detta förslag åsidosätter medlemsstaternas rättigheter i etiska frågor. De vill utesluta produkter som kommer från embryonala stamceller från förordningen. Följden av detta skulle bli att sådana produkter skulle vara oreglerade på många håll i EU när det gäller säkerhet, kvalitet och effektivitet. Tvärtemot dessa befängda påståenden leder inte förordningen till att medlemsstaternas rätt att vägra att godta embryonala, stamcellsbaserade behandlingsformer begränsas. Jag skulle faktiskt beklaga ett sådant förbud i alla medlemsstater. Denna förordning handlar om att rädda liv och om att höja livskvaliteten och inte om att förstöra liv – som vissa här i parlamentet påstår i kväll. Vi är skyldiga de tiotusentals patienterna och deras familjer att göra allt vi kan för att främja och göra de mest avancerade behandlingsformerna tillgängliga för några av de mest svårbehandlade sjukdomarna i dagens samhälle. Vi måste också så långt vi kan se till att de är säkra och håller så hög kvalitet som möjligt och att de faktiskt fungerar. Det är syftet med denna förordning. Jag stöder helt och hållet PSE-gruppens ståndpunkt och uppmanar alla ledamöter – särskilt mina irländska kolleger – att stödja denna förordning."@sv22
lpv:unclassifiedMetadata
"Proinsias De Rossa (PSE ). –"18,5,20,15,1,19,14,16,11,13,4
lpv:translated text
"Κύριε Πρόεδρε, θέλω να ευχαριστήσω όλες και όλους τους βουλευτές που μετείχαν στην ενδελεχή επεξεργασία του υπό συζήτηση κανονισμού. Είναι εξαιρετικά σημαντικό, θέματα τόσο ευαίσθητα και σύνθετα, όπως αυτό, να αντιμετωπίζονται στο πλαίσιο της διαδικασίας συναπόφασης. Είναι καθησυχαστικό για τους πολίτες μας, τα εθνικά κοινοβούλια των οποίων δεν μπορούν να μεταβάλουν έναν κανονισμό, να βλέπουν τους βουλευτές τους να μετέχουν στην εκπόνηση ισορροπημένης και αποτελεσματικής νομοθεσίας, η οποία αποσκοπεί στη βελτίωση των ζωών τους. Οι θεραπευτικές αγωγές, τις οποίες ο εν λόγω κανονισμός αποσκοπεί να εξετάσει, προσφέρουν μεγάλες δυνατότητες για τη θεραπεία του καρκίνου, της νόσου Αλτσχάιμερ και της νόσου Πάρκινσον. Δυστυχώς, και όχι απροσδόκητα, ορισμένα αντιδραστικά στοιχεία ισχυρίζονται αναληθώς ότι η παρούσα πρόταση παραβλέπει τα δικαιώματα των κρατών μελών σε ηθικά ζητήματα. Θέλουν να αποκλείσουν προϊόντα που προέρχονται από εμβρυϊκά βλαστοκύτταρα από το πεδίο εφαρμογής του εν λόγω κανονισμού. Το αποτέλεσμα αυτής της απαγόρευσης θα ήταν η μη κανονιστική ρύθμιση αυτών των προϊόντων σε πολλά μέρη της Ευρώπης όσον αφορά την ασφάλεια, την ποιότητα και την αποτελεσματικότητά τους. Αντίθετα με αυτούς τους εξωφρενικούς ισχυρισμούς, ο κανονισμός δεν περιορίζει το δικαίωμα του κράτους μέλους να αρνηθεί να επιτρέψει θεραπείες που βασίζονται σε εμβρυϊκά βλαστοκύτταρα. Στην πραγματικότητα, θα αποδοκίμαζα μια τέτοια απαγόρευση από οποιοδήποτε κράτος μέλος. Αυτός ο κανονισμός αφορά τη διάσωση της ζωής και τη βελτίωση της ποιότητας της ζωής, όχι την καταστροφή της – όπως ισχυρίζονται ορισμένοι απόψε στο παρόν Κοινοβούλιο. Έχουμε υποχρέωση απέναντι σε δεκάδες χιλιάδες ασθενείς και στις οικογένειές τους να κάνουμε ό,τι μπορούμε, προκειμένου να ενθαρρύνουμε και να καταστήσουμε δυνατές τις πιο προηγμένες θεραπείες για ορισμένες από τις πιο δύσκολες ασθένειες που αντιμετωπίζουν οι σημερινές μας κοινωνίες. Πρέπει επίσης να εγγυηθούμε, στον βαθμό που μπορούμε, ότι είναι ασφαλείς και υψηλής ποιότητας και ότι όντως είναι αποτελεσματικές. Αυτό αποσκοπεί να επιτύχει ο κανονισμός. Υποστηρίζω πλήρως τη θέση της Σοσιαλιστικής Ομάδας στο Ευρωπαϊκό Κοινοβούλιο και καλώ όλες και όλους τους βουλευτές –ιδιαίτερα δε καλώ όλες και όλους τους συναδέλφους μου από την Ιρλανδία– να υποστηρίξουν αυτόν τον κανονισμό."@el10
lpv:translated text
"Mr President, I would like to thank those Members who participated in the detailed processing of this regulation. It is extremely important that issues as sensitive and complex as this are dealt with under the codecision procedure. It reassures our citizens, whose national parliaments cannot vary a regulation, to see their MEPs engaged in preparing balanced and effective legislation which seeks to enhance their lives. The therapies which this regulation seeks to deal with have great potential for treating cancer, Alzheimer’s and Parkinson’s disease. Regrettably, and not unexpectedly, some reactionary elements are falsely claiming that this proposal overrides Member States’ rights on ethical issues. They want to exclude products derived from embryonic stem cells from the scope of this regulation. The effect of doing so would be to leave such products unregulated in many parts of Europe as regards their safety, quality and efficacy. Contrary to these wild claims, the regulation does not circumscribe a Member State’s right to refuse to countenance embryo, stem-cell-based therapies. Indeed I would deplore such a ban by any Member State. This regulation is about saving life and about enhancing the quality of life, not its destruction – as is being claimed by some in this House tonight. We owe it to tens of thousands of patients and their families to do everything we can to encourage and make available the most advanced treatments for some of the most intractable illnesses facing our societies today. We also need to guarantee insofar as we can that they are safe and of the highest quality and that they actually work. This is what this regulation seeks to do. I fully support the PSE Group’s position and call on all Members – and indeed I would particularly call on all my Irish colleagues – to support this regulation."@lv13
lpv:translated text
"Senhor Presidente, queria agradecer aos deputados que participaram no processo de exame detalhado da presente proposta de regulamento. É fundamental que a preparação de medidas tão delicadas e complexas como esta seja feita no quadro do processo de co-decisão. É tranquilizador para os nossos concidadãos, cujos parlamentos nacionais não podem modificar o disposto num regulamento, ver os seus deputados ao Parlamento Europeu empenhados na preparação de legislação equilibrada e eficiente que visa proporcionar-lhes uma maior esperança de vida. As terapias de que se ocupa o presente regulamento têm um grande potencial na área do tratamento do cancro e das doenças de Alzheimer e de Parkinson. Lamentável, mas não inesperadamente, alguns elementos reaccionários alegam falsamente que a proposta derroga os direitos dos Estados-Membros no domínio das questões éticas. Pretendem excluir os produtos derivados de células estaminais embrionárias do âmbito do regulamento. Isso levaria à perpetuação, em numerosas partes da Europa, da situação de ausência de regulação da segurança, qualidade e eficiência desses produtos. Contrariamente a tais falácias, o regulamento não cerceia aos Estados-Membros o direito de interditar as terapias baseadas em células estaminais embrionárias. Certamente que, para mim, uma tal interdição por qualquer Estado-Membro seria deplorável. Este regulamento visa salvar vidas e melhorar a qualidade de vida das pessoas e não destruí-las – como, esta noite, afirmaram alguns nesta Câmara. Temos, para com dezenas de milhares de pacientes e suas famílias, o dever de fazer tudo o que pudermos para encorajar e disponibilizar os tratamentos mais avançados no campo de algumas das doenças mais impiedosas que afligem hoje as nossas sociedades. Necessitamos também de garantir, na medida do possível, que eles sejam seguros e da máxima qualidade e que funcionem efectivamente. É esse o propósito do presente regulamento. Apoio cabalmente a posição do Grupo PSE e exorto todos os deputados – e gostaria de exortar especialmente todos os meus colegas irlandeses – a apoiar este regulamento."@pt17
lpv:translated text
"Herr Präsident! Ich möchte den Abgeordneten danken, die sich an der Erarbeitung dieser Verordnung im Detail beteiligt haben. Es ist ganz wichtig, dass so heikle und komplexe Themen wie dieses im Rahmen des Mitentscheidungsverfahrens behandelt werden. So werden unsere Bürgerinnen und Bürger, deren nationale Parlamente eine Verordnung nicht verändern können, beruhigt, wenn sich ihre Abgeordneten im Europäischen Parlament in die Erarbeitung von ausgewogenen und wirksamen Rechtsvorschriften einbringen, durch die ihr Leben verbessert werden soll. Die Therapien, mit denen sich diese Verordnung befasst, besitzen ein großes Potenzial für die Behandlung von Krebs, der Alzheimer- und der Parkinson-Krankheit. Leider – und das kommt nicht unerwartet – behaupten einige reaktionäre Elemente fälschlicherweise, dieser Vorschlag setze sich über die Rechte der Mitgliedstaaten in ethischen Fragen hinweg. Sie wollen Produkte, die von embryonalen Stammzellen stammen, vom Geltungsbereich dieser Verordnung ausschließen. Das hätte zur Folge, dass es in vielen Teilen Europas keine Regelung für die Sicherheit, Qualität und Wirksamkeit dieser Produkte gäbe. Entgegen diesen unsinnigen Behauptungen schränkt die Verordnung das Recht eines Mitgliedstaats nicht ein, embryonale Stammzelltherapien nicht zu dulden. Ich würde es übrigens bedauern, wenn ein Mitgliedstaat ein solches Verbot ausspräche. Bei dieser Verordnung geht es um die Rettung von Leben und die Verbesserung der Lebensqualität, nicht um die Vernichtung von Leben, wie Einige in diesem Hohen Haus am heutigen Abend behaupten. Wir sind es Zehntausenden Patienten und ihren Familien schuldig, alles in unserer Macht Stehende zu tun, um für die Behandlung einiger der schlimmsten Krankheiten, die heute unsere Gesellschaften heimsuchen, die fortgeschrittensten Therapien zu fördern und bereitzustellen. Außerdem müssen wir so weit wir können sichern, dass sie unbedenklich und von höchster Qualität sind und tatsächlich wirken. Das ist das Anliegen dieser Verordnung. Ich unterstütze voll und ganz den Standpunkt der PSE-Fraktion und fordere alle Abgeordneten auf – ja, ich fordere insbesondere alle meine irischen Kollegen auf –, dieser Verordnung ihre Zustimmung zu geben."@de9
lpv:spoken text
"Mr President, I would like to thank those Members who participated in the detailed processing of this regulation. It is extremely important that issues as sensitive and complex as this are dealt with under the codecision procedure. It reassures our citizens, whose national parliaments cannot vary a regulation, to see their MEPs engaged in preparing balanced and effective legislation which seeks to enhance their lives. The therapies which this regulation seeks to deal with have great potential for treating cancer, Alzheimer’s and Parkinson’s disease. Regrettably, and not unexpectedly, some reactionary elements are falsely claiming that this proposal overrides Member States’ rights on ethical issues. They want to exclude products derived from embryonic stem cells from the scope of this regulation. The effect of doing so would be to leave such products unregulated in many parts of Europe as regards their safety, quality and efficacy. Contrary to these wild claims, the regulation does not circumscribe a Member State’s right to refuse to countenance embryo, stem-cell-based therapies. Indeed I would deplore such a ban by any Member State. This regulation is about saving life and about enhancing the quality of life, not its destruction – as is being claimed by some in this House tonight. We owe it to tens of thousands of patients and their families to do everything we can to encourage and make available the most advanced treatments for some of the most intractable illnesses facing our societies today. We also need to guarantee insofar as we can that they are safe and of the highest quality and that they actually work. This is what this regulation seeks to do. I fully support the PSE Group’s position and call on all Members – and indeed I would particularly call on all my Irish colleagues – to support this regulation."@en4
lpv:unclassifiedMetadata
"Proinsias De Rossa (PSE ). –"18,5,20,15,1,19,14,16,11,13,4
lpv:translated text
"Señor Presidente, me gustaría dar las gracias a los diputados que han participado en la minuciosa tramitación de este Reglamento. Es sumamente importante que cuestiones tan sensibles y complejas como esta se tramiten por el procedimiento de codecisión. Tranquiliza a nuestros ciudadanos, cuyos Parlamentos nacionales no pueden modificar un reglamento, ver a sus diputados al Parlamento Europeo participar en la elaboración de una normativa equilibrada y eficaz que pretende mejorar sus vidas. Las terapias que aborda este Reglamento tienen un gran potencial para el tratamiento del cáncer y de las enfermedades de Alzheimer y Parkinson. Lamentable pero no inesperadamente, algunos elementos reaccionarios afirman que esta propuesta anula los derechos de los Estados miembros sobre cuestiones éticas, lo cual es falso. Quieren excluir los productos derivados de células madre embrionarias del ámbito de aplicación de este Reglamento. Esto haría que muchos productos quedaran sin regular en muchas partes de Europa en lo tocante a su seguridad, su calidad y su eficacia. Contrariamente a estas afirmaciones disparatadas, el Reglamento no limita el derecho de un Estado miembro a rechazar la aprobación de terapias basadas en células madre embrionarias. De hecho, yo lamentaría semejante prohibición por un Estado miembro. El presente Reglamento habla de salvar vidas y de mejorar la calidad de vida, no de su destrucción, como pretenden algunos en esta Cámara esta noche. Decenas de miles de pacientes y sus familias se merecen que hagamos todo lo posible por fomentar y poner a su disposición las terapias más avanzadas para algunas de las enfermedades más difíciles de tratar que existen en nuestra sociedad hoy en día. También tenemos que garantizar en la medida en que podamos que sean seguras y de la máxima calidad y que realmente sean eficaces. Este es el objetivo del presente Reglamento. Apoyo plenamente la posición del Grupo del PSE y pido a todos los diputados –particularmente a mis colegas irlandeses– que apoyen este Reglamento."@es21
lpv:translated text
"Monsieur le Président, je voudrais remercier ceux de mes collègues qui ont participé à toutes les étapes de l’élaboration de ce règlement. Il est extrêmement important que des questions aussi délicates et complexes soient traitées selon la procédure de codécision. Voir leurs députés européens engagés dans la préparation d’une législation équilibrée et efficace visant à améliorer leur qualité de vie rassure les citoyens européens, dont les parlements nationaux ne peuvent modifier un règlement. Les thérapies visées par ce règlement possèdent un important potentiel de traitement du cancer et des maladies d’Alzheimer et de Parkinson. Il est regrettable, mais pas surprenant, que certains éléments réactionnaires prétendent à tort que cette proposition fait fi des droits des États membres en matière de questions d’éthique. Ils veulent exclure les produits dérivés de cellules souches embryonnaires du champ d’application de ce règlement. Une telle exclusion entraînerait l’absence de réglementation concernant la sûreté, la qualité et l’efficacité de ces produits dans de nombreuses parties de l’Europe. Contrairement à ces prétentions absurdes, le règlement n’empêche pas un État membre d’exercer son droit de refuser d’approuver les thérapies basées sur les cellules souches embryonnaires. En fait, je déplorerais qu’un État membre décide une telle interdiction. Ce règlement permettra de sauver des vies et d’améliorer la qualité de la vie, non de la détruire, comme certains le prétendent dans cette Assemblée ce soir. Nous devons à des dizaines de milliers de patients et à leurs familles de faire tout ce qui est en notre pouvoir pour encourager la mise au point et mettre sur le marché les traitements les plus modernes pour certaines des maladies les plus complexes qui affectent aujourd’hui nos sociétés. Nous devons également garantir dans toute la mesure du possible qu’ils sont sûrs, de haute qualité et qu’ils sont réellement efficaces. Tel est le but de ce règlement. Je soutiens sans réserve la position du groupe PSE et j’appelle tous mes collègues - en particulier tous mes collègues irlandais - à soutenir ce règlement."@fr8
lpv:translated text
"Signor Presidente, desidero ringraziare i deputati che hanno partecipato alla meticolosa elaborazione di questo regolamento. E’ estremamente importante che questioni delicate e complesse come questa siano affrontate mediante la procedura di codecisione. E’ rassicurante per i cittadini, i cui parlamenti nazionali non possono emendare un regolamento, vedere che i loro deputati europei sono impegnati nel varo di una legislazione calibrata ed efficace volta a migliorare la loro vita. Le terapie che questa normativa intende affrontare potenzialmente possono curare il cancro, il morbo di Alzheimer e il morbo di Parkinson. Purtroppo, e non certo imprevedibilmente, alcuni esponenti reazionari dichiarano falsamente che la proposta cancella i diritti degli Stati membri nelle materie etiche. La loro intenzione è escludere i prodotti derivanti da cellule staminali embrionali dal campo d’azione del regolamento. In molte parti d’Europa, di conseguenza, la sicurezza, la qualità e l’efficacia di questi prodotti non verrebbero disciplinate in alcun modo. Contrariamente a quanto affermato in queste folli dichiarazioni, il regolamento non circoscrive il diritto degli Stati membri di rifiutarsi di sostenere le terapie basate sulle cellule staminali embrionali. Io stesso deplorerei un simile divieto in qualsiasi Stato membro. Questo regolamento è teso a salvare la vita e ad innalzarne la qualità, non a decretarne la distruzione – come ha detto qualcuno stasera. Abbiamo il dovere, verso decine di migliaia di malati e verso le loro famiglie, di adoperarci al massimo per incoraggiare e rendere disponibili i trattamenti più avanzati per alcune delle malattie meno curabili che attualmente funestano la nostra società. Dobbiamo inoltre garantire, entro le nostre possibilità, che tali trattamenti siano sicuri e della massima qualità e che siano anche efficaci. Sono questi i fini che il regolamento persegue. Sostengo appieno la posizione del gruppo PSE e chiedo a tutti i deputati – e mi rivolgono in particolar modo ai colleghi irlandesi – di appoggiare questo regolamento."@it12
rdf:type
dcterms:Date
dcterms:Is Part Of
dcterms:Language
lpv:document identification number
"en.20070423.17.1-111"6
lpv:hasSubsequent
lpv:speaker

Named graphs describing this resource:

1http://purl.org/linkedpolitics/rdf/Czech.ttl.gz
2http://purl.org/linkedpolitics/rdf/Danish.ttl.gz
3http://purl.org/linkedpolitics/rdf/Dutch.ttl.gz
4http://purl.org/linkedpolitics/rdf/English.ttl.gz
5http://purl.org/linkedpolitics/rdf/Estonian.ttl.gz
6http://purl.org/linkedpolitics/rdf/Events_and_structure.ttl.gz
7http://purl.org/linkedpolitics/rdf/Finnish.ttl.gz
8http://purl.org/linkedpolitics/rdf/French.ttl.gz
9http://purl.org/linkedpolitics/rdf/German.ttl.gz
10http://purl.org/linkedpolitics/rdf/Greek.ttl.gz
11http://purl.org/linkedpolitics/rdf/Hungarian.ttl.gz
12http://purl.org/linkedpolitics/rdf/Italian.ttl.gz
13http://purl.org/linkedpolitics/rdf/Latvian.ttl.gz
14http://purl.org/linkedpolitics/rdf/Lithuanian.ttl.gz
15http://purl.org/linkedpolitics/rdf/Maltese.ttl.gz
16http://purl.org/linkedpolitics/rdf/Polish.ttl.gz
17http://purl.org/linkedpolitics/rdf/Portuguese.ttl.gz
18http://purl.org/linkedpolitics/rdf/Romanian.ttl.gz
19http://purl.org/linkedpolitics/rdf/Slovak.ttl.gz
20http://purl.org/linkedpolitics/rdf/Slovenian.ttl.gz
21http://purl.org/linkedpolitics/rdf/Spanish.ttl.gz
22http://purl.org/linkedpolitics/rdf/Swedish.ttl.gz
23http://purl.org/linkedpolitics/rdf/spokenAs.ttl.gz

The resource appears as object in 2 triples

Context graph